Antonio Rivero

9.8k total citations
307 papers, 6.3k citations indexed

About

Antonio Rivero is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Antonio Rivero has authored 307 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Hepatology, 157 papers in Epidemiology and 156 papers in Infectious Diseases. Recurrent topics in Antonio Rivero's work include Hepatitis C virus research (115 papers), HIV/AIDS drug development and treatment (79 papers) and Liver Disease Diagnosis and Treatment (74 papers). Antonio Rivero is often cited by papers focused on Hepatitis C virus research (115 papers), HIV/AIDS drug development and treatment (79 papers) and Liver Disease Diagnosis and Treatment (74 papers). Antonio Rivero collaborates with scholars based in Spain, United States and Germany. Antonio Rivero's co-authors include Juan A. Pineda, Antonio Rivero‐Juárez, Juan Macı́as, Ángela Camacho, Julián Torre‐Cisneros, José Antonio López Mira, Mario Frías, Luís F. López‐Cortés, Juan F. Navarro‐González and Carmen Mora‐Fernández and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and The Science of The Total Environment.

In The Last Decade

Antonio Rivero

291 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Rivero Spain 40 3.3k 2.7k 2.6k 749 439 307 6.3k
Pier‐Angelo Tovo Italy 42 1.9k 0.6× 833 0.3× 1.8k 0.7× 1.2k 1.6× 606 1.4× 190 5.0k
Pierre‐Marie Girard France 50 2.8k 0.8× 1.5k 0.6× 3.6k 1.4× 2.9k 3.8× 1.2k 2.7× 243 7.2k
Hsin‐Yun Sun Taiwan 39 3.2k 1.0× 1.1k 0.4× 2.7k 1.1× 524 0.7× 505 1.2× 263 5.6k
Giampiero Carosi Italy 38 7.4k 2.2× 7.3k 2.7× 3.1k 1.2× 933 1.2× 479 1.1× 164 10.7k
F. Blaine Hollinger United States 46 5.4k 1.6× 4.6k 1.7× 1.7k 0.7× 961 1.3× 179 0.4× 164 7.9k
Massimo Puoti Italy 47 6.6k 2.0× 7.0k 2.6× 2.5k 0.9× 651 0.9× 571 1.3× 263 9.1k
Pierre–Yves Bochud Switzerland 37 2.9k 0.9× 1.5k 0.5× 1.2k 0.4× 176 0.2× 142 0.3× 115 4.8k
Esteban Ribera Spain 40 2.3k 0.7× 484 0.2× 3.0k 1.1× 1.7k 2.3× 1.0k 2.4× 231 5.5k
Emily A. Blumberg United States 44 4.5k 1.3× 1.2k 0.5× 2.0k 0.8× 168 0.2× 74 0.2× 185 7.0k
Amy Weintrob United States 34 1.6k 0.5× 447 0.2× 1.6k 0.6× 1.1k 1.4× 696 1.6× 98 4.0k

Countries citing papers authored by Antonio Rivero

Since Specialization
Citations

This map shows the geographic impact of Antonio Rivero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Rivero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Rivero more than expected).

Fields of papers citing papers by Antonio Rivero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Rivero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Rivero. The network helps show where Antonio Rivero may publish in the future.

Co-authorship network of co-authors of Antonio Rivero

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Rivero. A scholar is included among the top collaborators of Antonio Rivero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Rivero. Antonio Rivero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corma‐Gómez, Anaïs, Marı́a José Galindo, Ángela Camacho, et al.. (2025). FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure. Open Forum Infectious Diseases. 12(4). ofae628–ofae628.
2.
Izquierdo, Rebeca, Alejandro Vallejo, Inés Suárez‐García, et al.. (2025). Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(3). 274–282.
3.
López‐López, Pedro, María Á. Risalde, Javier Caballero‐Gómez, et al.. (2024). Prevalence of Paslahepevirus balayani in commercial swine food products from Spain. One Health. 18. 100690–100690. 1 indexed citations
4.
Montes, Marisa, Carmen Busca, Núria Espinosa, et al.. (2024). Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile. Open Forum Infectious Diseases. 11(4). ofae112–ofae112. 4 indexed citations
5.
López‐López, Pedro, Ángela Camacho, Javier Caballero‐Gómez, et al.. (2024). Serological and molecular survey of rat hepatitis E virus ( Rocahepevirus ratti ) in drug users. Emerging Microbes & Infections. 13(1). 2396865–2396865. 3 indexed citations
6.
Macı́as, Juan, Mario Frías, Juan A. Pineda, et al.. (2024). Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV. Alimentary Pharmacology & Therapeutics. 61(3). 550–557.
7.
Caballero‐Gómez, Javier, et al.. (2023). Butchering activity is the main risk factor for hepatitis E virus (Paslahepevirus balayani) infection in southwestern Nigeria: a prospective cohort study. Frontiers in Microbiology. 14. 1247467–1247467. 2 indexed citations
8.
González‐Serna, Alejandro, Anaïs Corma‐Gómez, Francisco Téllez, et al.. (2023). Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice. Journal of Antimicrobial Chemotherapy. 78(10). 2591–2596. 4 indexed citations
9.
Risalde, María Á., Mario Frías, Javier Caballero‐Gómez, et al.. (2022). Presence of hepatitis E virus in testis of naturally infected wild boars. Transboundary and Emerging Diseases. 69(6). 3317–3324. 6 indexed citations
10.
Rivero‐Juárez, Antonio, Mario Frías, Ana Belén Pérez, et al.. (2022). Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe. Journal of Hepatology. 77(2). 326–331. 81 indexed citations
11.
Corma‐Gómez, Anaïs, Juan Macı́as, Antonio Rivero, et al.. (2021). A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure. Diagnostics. 11(8). 1501–1501. 1 indexed citations
12.
Frías, Mario, Jose M. Moyano, Antonio Rivero‐Juárez, et al.. (2020). Classification Accuracy of Hepatitis C Virus Infection Outcome: Data Mining Approach. Journal of Medical Internet Research. 23(2). e18766–e18766. 3 indexed citations
13.
Rivero‐Juárez, Antonio, David Guijo-Rubio, Francisco Téllez, et al.. (2020). Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals. PLoS ONE. 15(1). e0227188–e0227188. 4 indexed citations
14.
Risalde, María Á., Antonio Rivero‐Juárez, Mario Frías, et al.. (2020). Evaluation of a non‐invasive screening approach to determine hepatitis E virus status of pig farms. Veterinary Record. 187(7). 272–272. 5 indexed citations
15.
Macı́as, Juan, Luís Morano, Francisco Téllez, et al.. (2019). Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. Journal of Hepatology. 71(1). 45–51. 44 indexed citations
16.
Rivero‐Juárez, Antonio, Luís F. López‐Cortés, Dolores Merino, et al.. (2016). Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy. European Journal of Clinical Microbiology & Infectious Diseases. 36(3). 487–494. 8 indexed citations
17.
Rivero‐Juárez, Antonio, Ángela Camacho, Celia Cifuentes, et al.. (2014). High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients. Journal of Infection. 70(6). 624–630. 26 indexed citations
18.
Knobel, Hernando, José M. Miró, Beatriz Mahíllo, et al.. (2004). Failure of Cetirizine to Prevent Nevirapine-Associated Rash. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1276–1281. 14 indexed citations
19.
Squires, Kathleen, Adriano Lazzarin, William G. Powderly, et al.. (2004). Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(5). 1011–1019. 238 indexed citations
20.
Santos, Jesús, et al.. (1994). [Bacteremia and recurrent arthritis caused by Streptococcus pyogenes in a heroin addict with AIDS].. PubMed. 12(8). 390–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026